Navigation Links
Bengt Roland Långström receives SNM's 2010 Georg Charles de Hevesy Nuclear Pioneer Award
Date:6/6/2010

SALT LAKE CITYBengt Roland Lngstrm, Ph.D., a professor in the department of biochemistry and organic chemistry at Uppsala University in Sweden, has been named as this year's recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession. Lngstrm was presented the award by SNMan international scientific and medical organizationduring its 57th Annual Meeting, June 5𔃇, in Salt Lake City, Utah.

In addition to his position as a professor of chemistry at Uppsala University, Lngstrm is the director of the Uppsala University PET Centre. He has more than 20 years of experience in the synthesis and applications of radiolabeled tracers for PET.

"Dr. Lngstrm heads up one of the most productive radiochemistry facilities in the world," said Michael M. Graham, Ph.D., M.D., 2009󈝶 president of SNM. "This prestigious award recognizes his achievements over the past 20 years."

Lngstrm has published more than 280 papers in chemistry and another 355 in research related to medicine and the life sciences. He has received several awards for his research, including the 1999 Arrhenius Award from the Swedish Chemical Society.

"I was so pleased to learn I was receiving this award," Lngstrm said. "It is both a professional and personal achievement for me, as well as an honor to be recognized by my colleagues."

Each year, SNM presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual for outstanding contributions to the field of nuclear medicine. De Hevesy received the 1943 Nobel Prize in chemistry for his work in determining the absorption, distribution, metabolism and elimination of radioactive compounds in the human body. His work led to the foundation of nuclear medicine as a tool for diagnosis and therapy and he is considered the father of nuclear medicine. SNM has given the de Hevesy Award every year since 1960 to honor groundbreaking work in the field of nuclear medicine.

"During his career at Uppsala University, Dr. Lngstrm has mentored numerous students in medicine and pharmacology, while making seminal contributions to radiochemistry and its application to nuclear medicine and studying many diseases," said David M. Goldenberg, Sc.D., M.D., Garden State Cancer Center, Belleville, N.J., who was the 2005 recipient of SNM's Paul C. Aebersold Award and introduced Lngstrm at SNM's 57th Annual Meeting.

"The list of previous recipients of this award is impressive and includes numerous Nobel laureatessuch as Ernest Lawrence, who built the world's first cyclotron for the production of radionuclides, and Glenn Seaborg, who discovered more than half a dozen new elements," said Graham. "Lngstrm joins a select group of scientists whose research is deemed to have had a significant impact on medicine."


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
2. Henry Gabelnick receives lifetime achievement award
3. Joan Miller, M.D., receives 2010 Leadership Award for the Advancement of Women Faculty
4. Man Receives Miracle – Able to Solve the Dead Sea Scrolls, Shroud of Turin, and Mysteries to Heaven
5. Aker BioMarine's Krill Fishery Receives Marine Stewardship Council Certification for Environmental Sustainability
6. Penn State receives Grand Challenges Explorations grant for innovative global health research
7. Physicians Preferred Wellness Group Receives Prestigious MD Preferred Service Award
8. National Water Services, Inc. Receives WBE Certification
9. Scott Harter at Atrion International Receives EHS Gold Award From PPG Industries
10. OUHSC receives $100,000 Grand Challenges Explorations grant for innovative global health research
11. Bloomberg School receives $100K Grand Challenges Explorations grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of ... college Bible teacher residing in North Carolina with his wife, Anna Marie. He and ... with six grandchildren. David is also the author of “Shadow and Substance.” , “Love, ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the National Council ... programs. The NCTQ report suggests, based on a review of GPA and SAT/ACT requirements ... quality in the U.S. It argues that this higher bar should be set by ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... and financial services firm serving the families and businesses of the Norwalk ... enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research ... Management in the U.S.: Consumer Strategies" report to their ... ... how adults approach and treat their physical pain, emphasizing consumer ... distinct groups: pain sufferers and adults who have selected illnesses/conditions ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology: